NIDAN
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-07-11
Trend
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
Price Action
Support & Resistance Levels
Volume Analysis
Recent Price Gaps
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Peer Comparison
Healthcare Service ProviderPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Dr. Lal Path Labs Ltd. | ₹1,692.80 | +0.49% | 55.7 | ₹28.36K Cr small Cap | |
| Vijaya Diagnostic Centre Limited | ₹1,389.10 | +0.82% | 82.6 | ₹14.29K Cr small Cap | |
| Thyrocare Technologies Limited | ₹515.70 | -3.71% | 50.8 | ₹8.21K Cr small Cap | |
| Nephrocare Health Services Limited | ₹649.00 | +2.46% | — | ₹6.51K Cr small Cap | |
| Metropolis Healthcare Limited | ₹567.95 | +1.41% | 61.6 | ₹2.94K Cr small Cap | |
| Krsnaa Diagnostics Limited | ₹556.65 | -0.04% | 17.8 | ₹1.81K Cr small Cap | |
| Suraksha Diagnostic Limited | ₹264.30 | +0.34% | 43.8 | ₹1.38K Cr small Cap | |
| Health X Platform Limited | ₹323.30 | -1.93% | 34.1 | ₹1.03K Cr small Cap | |
| 3B Blackbio Dx Limited | ₹1,148.60 | -1.64% | — | ₹986 Cr small Cap | |
| Chandan Healthcare Limited | ₹249.65 | -1.75% | 21.4 | ₹610 Cr small Cap | |
| Nidan Laboratories and Healthcare Limited | ₹13.95 | +2.95% | 12.9 | ₹19 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Sept 2024 | ANNUAL GENERAL MEETING | AGM |
| 18 Sept 2023 | ANNUAL GENERAL MEETING | AGM |
| 19 Sept 2022 | ANNUAL GENERAL MEETING | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NIDAN
View All
Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcare
Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials contained only water, not the active ingredient. The manufacturer, Jackson Laboratories, has had stop-production orders earlier as well. This incident has put focus on critical failures in drug regulation and raises serious concerns about patient safety.
India needs innovation at scale to fulfill ambition of becoming global discovery hub: Dr Reddy's
India must shift from minor advancements to large-scale innovation to become a global discovery hub, according to Dr. Reddy's Laboratories Chairman Satish Reddy. He emphasized the need for robust translational research pathways to ensure scientific breakthroughs benefit patients. The company's white paper highlights that stronger collaboration between academia, industry, and government is crucial for translating research into accessible healthcare solutions and overcoming existing challenges.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail: